Year archive

Luye Pharma Group Limited — 2015 filings

All 79 regulatory filings released by Luye Pharma Group Limited (2186) in 2015, sourced directly from the official regulator.

79 Filings

2015 Period

2015 filings (79)

Filing	Released	Lang
Terms of Reference for the Audit Committee of the board of directors of the Company Regulatory Filings	2015-12-30	English
ANNOUNCEMENT - COMPLETION OF TWO PHASE 1 CLINICAL STUDIES OF ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003) IN THE U.S. Regulatory Filings	2015-12-15	English
Interim Report And Unaudited Condensed Consolidated Interim Financial Information For the six months ended 30th September, 2015 Regulatory Filings	2015-12-15	English
ANNOUNCEMENT - ESTABLISHMENT OF A SUBSIDIARY Regulatory Filings	2015-12-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2015 Regulatory Filings	2015-12-04	English
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR LEVETIRACETAM EXTENDED RELEASE TABLET Regulatory Filings	2015-12-03	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-12-01	English
ANNOUNCEMENT OF CONDENSED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30TH SEPTEMBER, 2015 Regulatory Filings	2015-11-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2015-11-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2015 Regulatory Filings	2015-11-05	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-11-03	English
ANNOUNCEMENT - THE FDA CONFIRMED NO ADDITIONAL CLINICAL TRIALS ARE NEEDED FOR THE NDA SUBMISSION FOR LY03004 IN THE U.S. Regulatory Filings	2015-10-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2015 Regulatory Filings	2015-10-02	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-10-02	English
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS Regulatory Filings	2015-09-30	English
List of Directors and Their Role and Function Regulatory Filings	2015-09-29	English
Interim Report 2015 Regulatory Filings	2015-09-29	English
CLARIFICATION ANNOUNCEMENT - CHANGE IN DIRECTORATE Regulatory Filings	2015-09-17	English
CHANGE IN DIRECTORATE Regulatory Filings	2015-09-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2015 Regulatory Filings	2015-09-07	English
POLL RESULTS AT THE ANNUAL GENERAL MEETING HELD ON 2ND SEPTEMBER 2015 Regulatory Filings	2015-09-02	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-09-01	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2015 Regulatory Filings	2015-08-30	English
NOTICE OF BOARD MEETING Regulatory Filings	2015-08-18	English
ANNOUNCEMENT - COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN THE U.S. Regulatory Filings	2015-08-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2015 Regulatory Filings	2015-08-03	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-08-03	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2015-07-30	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 2ND SEPTEMBER, 2015 Regulatory Filings	2015-07-30	English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2015-07-30	English
ANNUAL REPORT 2014/15 Regulatory Filings	2015-07-30	English
UNUSUAL PRICE AND VOLUME MOVEMENTS Regulatory Filings	2015-07-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2015 Regulatory Filings	2015-07-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-07-03	English
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF PHASE 2 AND PHASE 3 CLINICAL TRIALS FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN CHINA Regulatory Filings	2015-07-02	English
ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2015 Regulatory Filings	2015-06-29	English
TERMINATION OF MAJOR TRANSACTION REFUND OF DEPOSIT Regulatory Filings	2015-06-24	English
NOTICE OF BOARD MEETING Regulatory Filings	2015-06-15	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 8 JUNE 2015 Regulatory Filings	2015-06-08	English
ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER Regulatory Filings	2015-06-05	English
COOPERATION FRAMEWORK AGREEMENT Regulatory Filings	2015-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2015 Regulatory Filings	2015-06-03	English
EXCHANGE NOTICE - RESUMPTION OF TRADING Regulatory Filings	2015-06-02	English
DISCLOSEABLE TRANSACTIONS - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS Regulatory Filings	2015-06-01	English
TERMINATION OF MAJOR TRANSACTION ACQUISITION OF EQUITY INTEREST IN BEIJING JIALIN PHARMACEUTICAL CO., LTD. AND RESUMPTION OF TRADING Regulatory Filings	2015-06-01	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-06-01	English
TRADING HALT Regulatory Filings	2015-06-01	English
EXCHANGE NOTICE - TRADING HALT Regulatory Filings	2015-06-01	English
ANNOUNCEMENT - THE COMPANY HAS SUCCESSFULLY COMPLETED THREE CLINICAL STUDIES FOR LY03004 IN THE U.S. Regulatory Filings	2015-05-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2015 Regulatory Filings	2015-05-07	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 8 JUNE 2015 Regulatory Filings	2015-05-06	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2015-05-06	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2015-05-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-05-04	English
Annual Report 2014 Regulatory Filings	2015-04-28	English
ANNOUNCEMENT - MARKETING AUTHORISATION FOR PANTOPRAZOLE ENTERIC-COATED TABLETS IN AUSTRIA Regulatory Filings	2015-04-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2015 Regulatory Filings	2015-04-09	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-04-08	English
Annual Results Announcement for the year ended 31 December 2014 Regulatory Filings	2015-03-31	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Regulatory Filings	2015-03-30	English
APPOINTMENT OF VICE EXECUTIVE CHAIRMAN Regulatory Filings	2015-03-30	English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2015-03-30	English
MAJOR TRANSACTION - ACQUISITION OF THE EQUITY INTEREST IN BEIJING JIALIN PHARMACEUTICAL CO., LTD. FULFILLMENT OF PERFORMANCE GUARANTEE Regulatory Filings	2015-03-30	English
Annual Results Announcement for the year ended 31 December 2014 Regulatory Filings	2015-03-30	English
COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN CHINA Regulatory Filings	2015-03-27	English
ANNOUNCEMENT - CLINICAL STUDY OF LY03004 DEMONSTRATES GENERALLY SIMILAR PHARMACOKINETIC AND SAFETY PROFILES IN U.S. PATIENTS TO A MARKETED PRODUCT IN THE SAME DOSAGE FORM Regulatory Filings	2015-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2015-03-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2015 Regulatory Filings	2015-03-05	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-03-02	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2015-02-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2015 Regulatory Filings	2015-02-04	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-02-02	English
MAJOR TRANSACTION - ACQUISITION OF THE EQUITY INTEREST IN BEIJING JIALIN PHARMACEUTICAL CO., LTD. - SUPPLEMENTAL AGREEMENT Regulatory Filings	2015-02-02	English
SHARE PLEDGE BY CONTROLLING SHAREHOLDER Regulatory Filings	2015-01-28	English
List of Directors and Their Role and Function Regulatory Filings	2015-01-20	English
POLL RESULTS OF SPECIAL GENERAL MEETING HELD ON 16 JANUARY 2015 Regulatory Filings	2015-01-16	English
UP-DATE ON INSIDE INFORMATION IN RELATION TO A POSSIBLE ACQUISITION Regulatory Filings	2015-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2014 Regulatory Filings	2015-01-06	English
Monthly Return of Equity Issuer on Movements in Securities Regulatory Filings	2015-01-02	English

Filings by year

2026 16 filings
2025 87 filings
2024 87 filings
2023 95 filings
2022 105 filings
2021 133 filings
2020 108 filings
2019 105 filings
2018 134 filings
2017 105 filings
2016 68 filings
2015 79 filings
2014 69 filings
2013 23 filings
2012 27 filings
2011 24 filings
2010 26 filings
2009 27 filings
2008 22 filings
2007 24 filings
2006 23 filings
2005 37 filings
2004 14 filings
2003 14 filings
2002 12 filings
2001 20 filings
2000 13 filings
1999 6 filings